Vitamin D Receptor Gene Sequence Variants in Type 1 Diabetes Show No Major Effect

Strategic Insights -

Type 1 diabetes research has been a focal point in the scientific community, particularly regarding the role of vitamin D in modulating the immune system. Recent studies have suggested that vitamin D administration may reduce the risk of type 1 diabetes, but the exact mechanisms and gene sequence variants involved are not well understood. A recent study analyzed the vitamin D receptor gene sequence variants in type 1 diabetes and their potential association with the disease.

Key Takeaways:

  • The study, conducted by researchers in England, Romania, Norway, and Finland, analyzed the association of 98 single nucleotide polymorphisms (SNPs) in the vitamin D receptor (VDR) gene with type 1 diabetes in up to 3,763 type 1 diabetic families.
  • The researchers found that the four most commonly studied SNPs of the VDR gene had no major effect on type 1 diabetes in the populations tested.
  • The study also genotyped all 98 SNPs in a minimum of 458 U.K. families with two affected offspring and further tested eight SNPs, including four SNPs associated with previous studies.
  • The investigation concluded that common sequence variation in the VDR gene has no major effect on type 1 diabetes in the populations tested.
  • The study was published in Diabetes and was conducted by Sergey Nejentsev at the University of Cambridge and collaborators in the U.K., Romania, Norway, and Finland.

Statistics:

  • 98 SNPs in the VDR gene were analyzed in the study.
  • Up to 3,763 type 1 diabetic families were included in the investigation.
  • 458 U.K. families with two affected offspring were genotyped for all 98 SNPs.
  • Eight SNPs, including four SNPs associated with previous studies, were further tested.
  • The study was published in Diagrams, a peer-reviewed journal of the American Diabetes Association.

Sources:

  • Diabetes (2004;53(10):2709-2712)
  • NewsRx.com & NewsRx.net (December 13, 2004)